MAUDE Adverse Event Report: STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS

Model Number	VICM5 12.6
Medical Device Problem Code	Misfocusing (1401)
Health Effect - Clinical Code	Blurred Vision (2137)
Type of Reportable Event	Malfunction
Additional Manufacturer Narrative
H6-investigation type 4110: lens work order search- no similar complaint event(s) within associated lots were found.Device description: the evo icl lens features an optic diameter that varies with the dioptric power; the smallest optic diameter being 4.9mm and the largest 6.1mm.The evo icl lens is capable of being folded and inserted into the posterior chamber through an incision of 3.5mm or less.The evo icl lens is intended to be placed entirely within the posterior chamber directly behind the iris and in front of the anterior capsule of the human crystalline lens.When correctly positioned, the evo icl lens functions as a refractive element to optically reduce moderate to high myopia with or without astigmatism.Mode of action: the icl lens functions as a refractive element to optically reduce moderate to high myopia with or without astigmatism.Warnings: a patient with mesopic pupil size that is greater than the optic diameter of the icl lens may experience symptoms of glare and/or halos.Patients should be advised about this potential risk prior to icl lens implantation.Precautions: prior to surgery, the surgeon must provide prospective patients with a copy of the patient information booklet for this product and inform these patients of the possible benefits and complications associated with the use of this device.- patients with higher degrees of myopia and/or myopic astigmatism experience lower efficacy and higher rates of adverse events (aes) and complications.- if a method of power calculation different from that used in the icl lens clinical study (i.E., lens power calculated by staar surgical using staar's proprietary software) is used, the effectiveness of the icl lens for myopia with or without astigmatism may not be consistent with the results reported in the icl lens clinical study results section.Claim#: (b)(4).
Event or Problem Description
The reporter indicated that a 12.6mm vicm5 12.6 implantable collamer lens of -6.00 diopter was implanted into the patient's eye on an unknown date.Residual refractive error is reported.The lens remains implanted.No further information has been provided.If additional information is received a supplemental medwatch report will be submitted.
Additional Manufacturer Narrative
Recall: if remedical action initiated, check type: "recall" should be added.Correction/removal number: if action reported to fda under 21 usc 360i(f), list correction/removal reporting number: "2023826-10/16/2023-001-r" should be added.Claim# (b)(4).

• Brand Name: IMPLANTABLE COLLAMER LENS (ICL)
• Common Device Name: PHAKIC INTRAOCULAR LENS
• Manufacturer (Section D): STAAR SURGICAL COMPANY; 1911 walker avenue; monrovia CA 91016
• Manufacturer (Section G): STAAR SURGICAL COMPANY; 1911 walker avenue; monrovia CA 91016
• Manufacturer Contact: joselene muniz ; 1911 walker avenue; monrovia, CA 91016
• MDR Report Key: 18187772
• Report Number: 2023826-2023-04974
• Device Sequence Number: 7215386
• Product Code: MTA
• UDI-Device Identifier: 00841542119108
• UDI-Public: 00841542119108
• Combination Product (Y/N): N
• Initial Reporter State: FL
• Initial Reporter Country: US
• PMA/510(K) Number: P030016
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Health Professional
• Initial Reporter Occupation: Other Health Care Professional
• Remedial Action: Recall
• Type of Report: Initial,Followup
• Report Date (Section B): 11/01/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 10/31/2024
• Device Model Number: VICM5 12.6
• Device Catalogue Number: N/A
• Device Lot Number: N/A
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 11/01/2023
• Supplement Date Received by Manufacturer: 02/14/2024
• Initial Report FDA Received Date: 11/21/2023
• Supplement Report FDA Received Date: 02/14/2024
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 12/06/2022
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• If action reported to FDA under 21 USC 360i(g), list FDA-assigned Recall Number or include a statement: 2023826-10/16/2023-001-R
• Patient Sequence Number: 1
• Patient Sex: Unknown